SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-24-020995
Filing Date
2024-06-21
Accepted
2024-06-21 17:00:55
Documents
1
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 6771
  Complete submission text file 0001437749-24-020995.txt   8167
Mailing Address 5300 MEMORIAL DRIVE, SUITE 950 HOUSTON TX 77007
Business Address
KLEMP WALTER V (Reporting) CIK: 0000938419 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37758 | Film No.: 241061257

Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Issuer) CIK: 0001659617 (see all company filings)

IRS No.: 474671997 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)